Expert consensus on the diagnosis of recurrent or metastatic nasopharyngeal carcinoma
Committee of Nasopharyngeal Cancer of Chinese Anti-Cancer Association, Li Jingao, Chen Xiaozhong, Lin Shaojun, Hu Chaosu
Department of Radiation Oncology,Jiangxi Cancer Hospital,Nanchang 330029,China (Li JG); Department of Radiation Oncology,Fujian Cancer Hospital,Fuzhou 350005,China (Lin SJ); Department of Radiation Oncology,zhejian Cancer Hospital,Hangzhou 310022,China (Chen XZ); Department of Radiation Oncology,Cancer Hospital,Fuda University,Shanghai 200032,China (Hu CS)
Abstract：Locoregional recurrenceand distant metastasis are the major reasons for nasopharyngeal carcinoma (NPC) treatment failure. Nearly 10% of patients suffer locoregional recurrenceafter intensity-modulated radiotherapy with or without chemotherapy. Additionally,4% to 10% of patients newly diagnosed with NPC and 15% to 30% of patients receiving radical treatment have distant metastasis. Early accurate diagnosis and timely intervention contribute to better therapeutic outcomes of recurrent or metastatic NPC,because salvage therapy based on misdiagnosis may bring severe complications to patients. To date,there are no global guidelines or expert consensus on the diagnosis of recurrent or metastatic NPC.Herein,this expert consensus raisesthe recommendations and suggestions for the diagnosis ofrecurrent or metastatic NPC,providing a reference for clinical practice.
Committee of Nasopharyngeal Cancer of Chinese Anti-Cancer Association,Li Jingao,Chen Xiaozhong et al. Expert consensus on the diagnosis of recurrent or metastatic nasopharyngeal carcinoma[J]. Chinese Journal of Radiation Oncology, 2018, 27(1): 7-15.
[1] Parkin DM,Whelan SL,Ferlay J,et al. Cancer incidence in five continents:vol VⅢ:IARC Scientific Publication NO.155[M].Lyon:International Agency for Research on Cancer,2002 [2] Setton J,Han J,Kannarunimit D,et al. Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma[J].Oral Oncol,2016,53:67-73.DOI:10.1016/j.oraloncology.2015.11.015 [3] Peng G,Wang T,Yang KY,et al. A prospective,randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs.conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma[J].RadiotherOncol,2012,104(3):286-293.DOI:10.1016/j.radonc.2012.08.013 [4] Sun XM,Su SF,Chen CY,et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma:an analysis of survival and treatment toxicities[J].RadiotherOncol,2014,110(3):398-403.DOI:10.1016/j.radonc.2013.10.020 [5] Chua MLK,Wee JTS,Hui EP,et al.Nasopharyngeal carcinoma[J].Lancet,2016,387(10022):1012-1024.DOI:10.1016/S0140-6736(15)00055-0 [6] Lee AWM,Ng WT,Chan LK,et al.The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement[J].Oral Oncol,2012,48(10):1007-1013.DOI:10.1016/j.oraloncology.2012.03.022 [7] Lee AWM,Ma BBY,Ng WT,et al. Management of nasopharyngeal carcinoma:current practice and future perspective[J].J ClinOncol,2015,33(29):3356-3364.DOI:10.1200/JCO.2015.60.9347 [8] Tian YM,Tian YH,Zeng L,et al. Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy[J].Br J Cancer,2014,110(2):297-303.DOI:10.1038/bjc.2013.715 [9] Chee J,Loh KS,Tham I,et al. Prognostic stratification of patients withmetastaticnasopharyngeal carcinomausing a clinical and biochemical scoring system[J].J Cancer Res Clin Oncol,2017,143(12):2563-2570.DOI:10.1007/s00432-017-2496-1 [10] Tian YM,Guan Y,Xiao WW,et al. Long-term survival and late complications in intensity-modulated radiotherapy of locallyrecurrentT1 to T2nasopharyngeal carcinoma[J].Head Neck,2016,38(2):225-231.DOI:10.1002/hed.23880 [11] StokerSD, van Diessen JN, de Boer JP,et al. Current treatment options for local residual nasopharyngeal carcinoma[J].Cur Treat Opt Oncol,2013,14(4):475-491 [12] ChuaD. Management of patients with failure following definitive radiation therapy: reirradiation in patients with locally recurrent nasopharyngeal carcinoma[A]//Lu JJ, Cooper JS,Lee AWM.Nasopharyngeal cancer,multidisplinary management[M].Heidelberg:Springer,2010:241-251 [13] Ragab SM,Erfan FA,Khalifa MA,et al. Detection of local failures after management of nasopharyngeal carcinoma:a prospective,controlled trial[J].J LaryngolOtol,2008,122(11):1230-1234.DOI:10.1017/S0022215108002016 [14] Baatenburg de Jong RJ,Rongen RJ,LamérisJS,et al. Metastatic neck disease:palpation vs. ultrasound examination[J].Arch Otolaryngol Head Neck Surg,1989,115(6):689-690.DOI:10.1001/archotol.1989.01860300043013 [15] 胡学锋,蒋军,卢秋霞,等.鼻咽癌颈淋巴结转移灶的B超扫描与临床触诊的对比研究[J].实用癌症杂志,2001,16(2):201-203.DOI:10.3969/j.issn.1001-5930.2001.02.032.Hu XF,Jiang J,Lu QX,et al. Comparative study of ultrasound scan and clinical palpation in the cervical lymph node metastasis of nasopharyngeal carcinoma[J].J Pract Cancer,2001,16(2):201-203.DOI:10.3969/j.issn.1001-5930.2001.02.032 [16] 王琦.颈部肿瘤淋巴结转移的影像学诊断[J].国外医学临床放射学分册,2002,25(6):338-340.DOI:10.3784/j.issn.1674-1897.2002.06.005.Wang Q. Imaging diagnosis of lymph node metastasis in cervical cancer[J].Fore Med Sci (Clin Radiol Arch),2002,25(6):338-340.DOI:10.3784/j.issn.1674-1897.2002.06.005 [17] Ng RHW,Ngan R,Wei WI,et al. Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma[J].Otolaryngol Head Neck Surg,2014,150(4):602-609.DOI:10.1177/0194599813520136 [18] Lam JWK,Chan JYW,Ho WK,et al. Use of transoral nasopharyngeal brush biopsy for Epstein-Barr virus DNA detection of local recurrence of nasopharyngeal carcinoma after radiotherapy[J].Head Neck,2016,38(S1):E1301-E1304.DOI:10.1002/hed.24216 [19] Hao SP,Tsang NM,Chang KP.Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and Epstein-Barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma[J].Laryngoscope,2004,114(11):2027-2030.DOI:10.1097/01.mlg.0000147941.75002.d4 [20] Li S,Deng Y,Li X,et al. Diagnostic value of Epstein-Barr virus capsid antigen-IgA in nasopharyngeal carcinoma:a meta-analysis[J].Chin Med J,2010,123(9):1201-1205.DOI:10.3760/cma.j.issn.0366-6999.2010.09.018 [21] 季明芳,郭媛卿,梁锦胜,等.鼻咽癌患者发病前后EB病毒VCA/IgA和EA/IgA滴度动态分析[J].中华肿瘤杂志,2003,25(3):243-245.DOI:10.3760/j.issn:0253-3766.2003.03.010.Ji MF,Guo YQ,Liang JS,et al. A dynamic analysis of ebv/IgA and EA/IgA drops before and after the onset of nasopharyngeal carcinoma[J].Chin J Oncol,2003,25(3):243-245.DOI:10.3760/j.issn:0253-3766.2003.03.010 [22] Lo YMD,Chan LYS,Lo KW,et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma[J].Cancer Res,1999,59(6):1188-1191 [23] To EWH,Chan KCA,Leung SF,et al. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma[J].Clin Cancer Res,2003,9(9):3254-5259 [24] Lo YMD,Leung SF,Chan LYS,et al. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma[J].Cancer Res,2000,60(9):2351-2355 [25] Wang WY,Twu CW,Lin WY,et al. Plasma Epstein-Barr virus DNA screening followed by 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma[J].Cancer,2011,117(19):4452-4459.DOI:10.1002/cncr.26069 [26] Leung SFL,Lo YMD,Chan ATC,et al. Disparity of sensitivities in detection of radiation-naǐveand postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2[J].Clin Cancer Res,2003,9(9):3431-3434 [27] Hsu CL,Chan SC,Chang KP,et al. Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma[J].Oral Oncol,2013,49(6):620-625.DOI:10.1016/j.oraloncology.2013.02.006 [28] Liu T,Xu W,Yan WL,et al. FDG-PET,CT,MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma,which one is the best? A systematic review[J].RadiotherOncol,2007,85(3):327-335.DOI:10.1016/j.radonc.2007.11.002 [29] Zhou HZ,Shen GH,Zhang WJ,et al.18F-FDG PET/CT for the diagnosis of residual or recurrent nasopharyngeal carcinoma after radiotherapy:ametaanalysis[J].J Nucl Med,2016,57(3):342-347.DOI:10.2967/jnumed.115.165407 [30] 张华,李国文,谢爱民,等.PET-CT和MRI在诊断鼻咽癌放疗后复发中的价值[J].现代肿瘤医学,2010,18(11):2123-2127.DOI:10.3969/j.issn.1672-4992.2010.11.14.Zhang H,Li GW,Xie AM,et al. The value of pet-ct and MRI in the diagnosis of recurrent nasopharyngeal carcinoma[J].Mode Oncol Med,2010,18(11):2123-2127.DOI:10.3969/j.issn.1672-4992.2010.11.14 [31] Ng SH,Joseph CTC,Chan SC,et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence[J].J Nucl Med,2004,45(10):1669-1676 [32] 徐文.CT、MRI在头颈癌预淋巴结转移早期诊断中的应用[J].国外医学耳鼻咽喉科学分册,1996,20(2):94-96.Xu W. The application of CT and MRI in early diagnosis of precancerous lymph node metastasis[J].Fore Med Sci (Otol Ngol Med Arch),1996,20(2):94-96 [33] Al-Amro A,Saleem M,Bakheet S,et al. The role of 18-FDG positron emission tomography (FDG-PET) in detecting post-radiotherapy loco regional relapse/residual disease in nasopharyngeal cancer[J].J Egypt Natl Canc Inst,2009,21(4):279-285 [34] 吕洁瑜,梁发雅,韩萍,等.应用内镜技术诊断鼻咽癌放疗后鼻咽颅底病变的价值[J].中华肿瘤杂志,2017,39(5):384-388.DOI:10.3760/cma.j.issn.0253-3766.2017.05.013.Lyu JY,Liang FY,Han P,et al. The value of nasopharyngeal lesions after radiotherapy of nasopharyngeal carcinoma was diagnosed by endoscopic technique[J].Chin J Oncol,2017,39(5):384-388.DOI:10.3760/cma.j.issn.0253-3766.2017.05.013 [35] Toh ST,Yuen HW,Goh YH,et al. Evaluation of recurrent nodal disease after definitive radiation therapy for nasopharyngeal carcinoma:diagnostic value of fine-needle aspiration cytology and CT scan[J].Head Neck,2007,29(4):370-377.DOI:10.1002/hed.20526 [36] Toh ST,Yuen HW,Lim KH,et al. Residual cervical lymphadenopathy after definitive treatment of nasopharyngeal carcinoma:fine needle aspiration cytology,computed tomography and histopathological findings[J].J LaryngolOtol,2011,125(1):70-7.DOI:10.1017/S0022215110001933 [37] Chan ATC,Lo YMD,Zee B,et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma[J].J Natl Cancer Inst,2002,94(21):1614-1619.DOI:10.1093/jnci/94.21.1614 [38] 龚晓昌,李金高,袁霞,等.血浆EBVDNA水平测定在监测鼻咽癌放疗后复发、转移中的临床意义[J].实用癌症杂志,2007,22(2):150-153.DOI:10.3969/j.issn.1001-5930.2007.02.011.Gong XC,Li JG,Yuan X,et al.Plasma EBV-DNA level measurement in monitoring recurrence and metastasis after radiotherapy nasopharyngeal carcinoma in clinical significance[J].J Pract Cancer,2007,22(2):150-153.DOI:10.3969/j.issn.1001-5930.2007.02.011 [39] Teo PM, Kwan WH, Lee WY, et al. Prognosticators determining survival subsequent to distantmetastasis from nasopharyngeal carcinoma. Cancer,1996,77:2423-2431 [40] Liu FY,Lin CY,Chang JT,et al.18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma[J].J Nucl Med,2007,48(10):1614-1619.DOI:10.2967/jnumed.107.043406 [41] Lukaszewski B,Nazar J,Goch M,et al. Diagnostic methods for detection of bone metastases[J].ContempOncol,2017,21(2):98-103.DOI:10.5114/wo.2017.68617 [42] Monfardini L,Preda L,Aurilio G,et al. Ct-guided bone biopsy in cancer patients with suspected bone metastases:retrospective review of 308 procedures[J].Radiol Med,2014,119(11):852-860.DOI:10.1007/s11547-014-0401-4 [43] Shif Y,Kung JW,McMahon CJ,et al. Safety of omitting routine bleeding tests prior to image-guided musculoskeletal core needlebiopsy[J].Skeletal Radiol,2017.DOI:10.1007/s00256-017-2784-5.(in Press)[44] Barrientos-Ruiz I,Ortiz-Cruz EJ,Serrano-Montilla J,et al. Are biopsy tracts a concern for seeding and local recurrence in sarcomas?[J].ClinOrthopRelat Res,2017,475(2):511-518.DOI:10.1007/s11999-016-5090-y [45] 韩玉成,袁越,初建国,等.15 mm以下周围型小肺癌的影像学检出和诊断[J].中华肿瘤杂志,2001,23(1):60-63.Han YC,Yuan Y,Chu JG,et al. Imaging detection and diagnosis of small lung cancer around 15 mm[J].Chin J Oncol,2001,23(1):60-63 [46] Macherey S,Doerr F,Heldwein M,et al. Is manual palpation of the lung necessary in patients undergoing pulmonary metastasectomy?[J].InteractCardioVascThoracSurg,2016,22(3):351-359.DOI:10.1093/icvts/ivv337 [47] Margaritora S,Porziella V,D’Andrilli,et al. Pulmonary metastases:can accurate radiological evaluation avoid thoracotomic approach?[J].Eur J CardiothoracSurg,2002,21(6):1111-1114.DOI:10.1016/S1010-7940(02)00119-7 [48] Ambrogi V,Paci M,Pompeo E,et al. Transxiphoid video-assisted pulmonary metastasectomy:relevance of helical computed tomography occult lesions[J].Ann ThoracSurg,2000,70(6):1847-1852.DOI:10.1016/S0003-4975(00)01806-3 [49] Diederich S,Semik M,Lentschig MG,et al. Helical CT of pulmonary nodules in patients with extrathoracic malignancy:CT-surgical correlation[J].AJR Am J Roentgenol,1999,172(2):353-360.DOI:10.2214/ajr.172.2.9930781 [50] Waters DJ,Coakley FV,Cohen MD,et al. The detection of pulmonary metastases by helical CT:aclinicopathologic study in dogs[J].J Comput Assist Tomogr,1998,22(2):235-240.DOI:10.1097/00004728-199803000-00014 [51] Gould MK,Maclean CC,Kuschner WG,et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and masslesions:a meta-analysis[J].JAMA,2001,285(7):914-924.DOI:10.1001/jama.285.7.914 [52] Deppen SA,Blume JD,Kensinger CD,et al. Accuracy of FDG-PETto diagnose lung cancer in areas with infectious lung disease:a meta-analysis[J].JAMA,2014,312(12):1227-1236.DOI:10.1001/jama.2014.11488 [53] Anzidei M,Porfiri A,Andrani F,et al. Imaging-guided chest biopsies:techniques and clinical results[J].Insights Imaging,2017,8(4):419-428.DOI:10.1007/s13244-017-0561-6 [54] Glover CMA,Douse P,Kane PFRCR,et al. Accuracy of investigations for asymptomatic colorectal liver metastases[J].Dis Colon Rectum,2002,45(4):476-484.DOI:10.1007/s10350-004-6224-y [55] Xu C,Zhang Y,Peng L,et al. Optimal modality for detecting distant metastasis in primary nasopharyngeal carcinoma during initial staging:a systemic review and meta-analysis of 1774 patients[J].J Cancer,2017,8(7):1238-1248.DOI:10.7150/jca.18361 [56] Shiozawa K,Watanabe M,Ikehara T,et al. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer[J].J Clin Ultrasound,2017,45(3):138-144.DOI:10.1002/jcu.22421 [57] SpǎrchezZ,Radu P,Kacso G,et al. Prospective comparison between real time contrast enhanced and conventional ultrasound guidance in percutaneous biopsies of liver tumors[J].Med Ultrason,2015,17(4):456-463.DOI:10.11152/mu.2013.2066.174.deu [58] Kuo FY,Chen WJ,Lu SN,et al. Fine needle aspiration cytodiagnosis of liver tumors[J].ActaCytol,2004,48(2):142-148.DOI:10.1159/000326307 [59] 吴薇,陈敏华,严昆,等.超声造影对提高肝肿瘤穿刺活检诊断率的应用价值[J].中华医学杂志,2006,86(2):116-120.DOI:10.3760/j:issn:0376-2491.2006.02.010.Wu W,Chen MH,Yan K,et al. The application of ultrasonography to improve the diagnostic rate of the biopsy of liver tumors[J].Chin J Med,2006,86(2):116-120.DOI:10.3760/j:issn:0376-2491.2006.02.010 [60] Kalambokis G,Manousou P,Vibhakorn S,et al. Transjugular liver biopsy-indications, adequacy, quality of specimens, and complications-a systematic review[J].J Hepatol,2007,47(2):284-294
2018, Vol. 27 
